Jill Fiedler-Kelly is President of the Cognigen division of Simulations Plus, Inc. Ms. Fiedler-Kelly co-founded Cognigen in 1992 along with two other partners and grew the company over the last 30 years. Cognigen provides consulting services to pharmaceutical and biotechnology companies around the globe, assisting them with strategic design and implementation of pharmacometric modeling and simulation approaches in new drug development programs. Ms. Fiedler-Kelly is an Adjunct Professor of Pharmaceutical Sciences at the University at Buffalo, where she teaches workshops and assists with a graduate course in population PK/PD. Ms. Fiedler-Kelly co-authored an introductory pharmacometrics textbook entitled Introduction to Population PK/PD Analysis with Nonlinear Mixed Effects Models in conjunction with Dr. Joel Owen. She has also published numerous scientific papers in peer-reviewed journals, has presented at national and international symposia, and has held leadership positions in organizations such as the East Coast Population Analysis Group, the Population PK/PD Focus Group of AAPS, and recently served a term on the Board of Directors of ASCPT. In 2016, she was named a Fellow of the International Society of Pharmacometrics.
Disclosure information not submitted.
Friday, March 18, 2022
3:45 PM – 4:45 PM ET
.png)